Company / Capital Expenditures
PROCEPT BioRobotics Corp Capital Expenditures History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$9.4M
FY2025
5-year range
$592.0K / $25.2M
FY2021-FY2025
Trend
+112.2%
vs FY2024
Sector context
#113 of 147
Health Care
What the data says
PROCEPT BioRobotics Corp's capital expenditures of $9M is lower than 77% of companies in the Health Care sector (FY2025). Declined from $25M to $9M over the past 2 years.
Based on SEC 10-K filings.
$9M in FY2025 with a 5-year CAGR of +109.3%.
Declined from $25M to $9M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +52.2%
- 5-Year CAGR
- +109.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 23% in Health CareTop 77% of 147This company $9.4M Sector average $266.4M
▼
-96.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +109.3%, indicating consistent growth.
- In FY2025, capital expenditures increased 112.2% year-over-year.
- Ranks #113 out of 147 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.4M | +112.2% |
| FY2024 | $4.4M | -82.5% |
| FY2023 | $25.2M | +850.1% |
| FY2022 | $2.7M | +348.1% |
| FY2021 | $592.0K | +154.1% |
| FY2020 | $233.0K | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026